Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
The newly introduced Novaplex™ MPXV/OPXV plus Assay (RUO) is designed to detect 3 targets causing mpox disease: non-variola ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A safety update for abrocitinib has shown the drug to be ...
Shingles, also known as herpes zoster, occurs when the dormant chickenpox ... Shingles is in the same viral family as herpes simplex. At first, it may be difficult to tell the two conditions ...
VZV has many of the same characteristics as herpes simplex virus type 1 (HSV-1), commonly linked ... where it can reactivate in later life in a painful rash called shingles (herpes zoster). Because ...
has been demonstrated preclinically to be more effective in the destruction of the Herpes Simplex Virus 1 ("HSV-1") than the currently approved standard of care drug, Acyclovir. Acyclovir is an ...
Background: Herpes zoster is more prevalent among the older adult due to the age-related immune decline, leading to significant pain and complications. Although vaccination effectively prevents viral ...
As herpes simplex is most often acquired during delivery rather than during gestation, it is more preventable and treatable compared with CMV or rubella. Like the varicella-zoster virus ...
It can happen after infection with a herpes virus, including herpes simplex virus 1 and 2, varicella-zoster virus, and Epstein-Barr virus. Common symptoms include headache, fever, and neck pain. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback